Introduction to Ultibro Breezhaler (Indacaterol+Glycopyrronium) 10mg
DILBRO UNICAP (Indacaterol+Glycopyrronium) 10mg is a prescription respiratory medicine used for the long-term management of chronic obstructive pulmonary disease (COPD). It combines two bronchodilators—Indacaterol, a long-acting beta-2 agonist (LABA), and Glycopyrronium, a long-acting muscarinic antagonist (LAMA)—to help open airways and improve breathing.
DILBRO UNICAP (Indacaterol+Glycopyrronium) 10mg is classified under Prescription Medicines, Respiratory Medicines, Bronchodilator Combination Drugs, and Oral/Inhalation Therapies. It helps relieve airway obstruction, reduce breathlessness, and improve lung function in patients with COPD.
In some markets, Ultibro Breezhaler is available as the original brand containing the same active ingredients, offering similar therapeutic effects when prescribed by a qualified healthcare professional.
What Is Ultibro Breezhaler (Indacaterol+Glycopyrronium)?
Ultibro Breezhaler is the original brand name for the combination of Indacaterol and Glycopyrronium, an inhaled medication widely used for long-term management of COPD.
Indacaterol is a long-acting beta-2 agonist (LABA) that relaxes airway muscles, while Glycopyrronium is a long-acting muscarinic antagonist (LAMA) that reduces airway constriction.
Generic versions such as DILBRO UNICAP 10mg contain the same active compounds and may be used depending on physician recommendation and regional availability.
Drug Class and Mechanism of Action
This medicine is classified as a combination bronchodilator (LABA + LAMA) with airway-relaxing and long-acting bronchodilatory properties.
How DILBRO UNICAP Works
It works in several ways:
- Indacaterol relaxes airway smooth muscles via beta-2 receptor activation
- Glycopyrronium blocks muscarinic receptors to prevent airway constriction
- Combined, they improve airflow, reduce breathlessness, and enhance lung function
Through these mechanisms, DILBRO UNICAP provides sustained bronchodilation for COPD patients.
How Ultibro Breezhaler Works in the Body
In COPD, airways are narrowed due to inflammation and muscle constriction. Indacaterol and Glycopyrronium together open the airways, improving oxygen flow and easing breathing.
Key Actions of Indacaterol+Glycopyrronium
- Sustained bronchodilation
- Reduced airway resistance
- Relief from dyspnea (shortness of breath)
- Improved exercise tolerance
Generic versions such as DILBRO UNICAP deliver the same active compounds for effective COPD management under medical supervision.
Medical Uses of Ultibro Breezhaler (Indacaterol+Glycopyrronium) 10mg
Indacaterol+Glycopyrronium 10mg is prescribed for the long-term management of COPD.
DILBRO UNICAP for COPD
It is commonly used to:
Potential Benefits
- Reduce COPD exacerbations
- Improve lung function and airflow
- Reduce breathlessness and improve quality of life
- Enhance exercise capacity in COPD patients
Generic alternatives like DILBRO UNICAP 10mg may also be used under medical supervision.
Who Can Take DILBRO UNICAP 10mg?
Because this is a potent inhaled bronchodilator, it should be used under medical supervision.
Eligibility Criteria
Patients may be prescribed this medicine if they:
- Have a confirmed diagnosis of COPD
- Require long-term maintenance bronchodilator therapy
- Can follow proper inhalation technique and dosage instructions
Certain generic options such as DILBRO UNICAP may also be considered depending on availability and physician decision.
Who Should Avoid Ultibro Breezhaler (Indacaterol+Glycopyrronium) 10mg
This medicine should NOT be used by:
- Patients with hypersensitivity to Indacaterol, Glycopyrronium, or similar bronchodilators
- Individuals with severe heart rhythm disorders
- Pregnant or breastfeeding women without medical advice
Ultibro Breezhaler (Indacaterol+Glycopyrronium) 10mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage recommendations include:
- 1 capsule inhaled once daily using a dry powder inhaler
- Inhalation should be performed at the same time each day
- Do not exceed the prescribed dose
Dosage Adjustments
Doctors may adjust the dose depending on:
- Severity of COPD
- Patient response and tolerance
- Concomitant use of other respiratory medications
Side Effects of DILBRO UNICAP 10mg
Common Side Effects
- Cough
- Throat irritation
- Headache
- Mild dizziness
Serious Side Effects
- Rapid or irregular heartbeat
- Severe allergic reactions
- Shortness of breath worsening
- Muscle cramps or tremors
Patients should report any unusual symptoms to their doctor immediately.
Storage:
Store below 25°C in a cool, dry place, protected from moisture and sunlight. Keep out of reach of children.
Frequently Asked Questions (FAQs)
1. Is Ultibro Breezhaler 10mg safe for long-term use?
Yes, it can be used long-term under regular medical supervision for COPD management.
2. Can I use it during an acute COPD exacerbation?
No. It is intended for maintenance therapy, not for acute symptom relief.
3. Can I take other inhalers with DILBRO UNICAP?
Yes, but only under doctor guidance to avoid interactions.
4. Can children take this medicine?
It is generally prescribed only for adults with COPD.
5. Is it safe during pregnancy?
Only if clearly prescribed by a doctor; generally avoided during pregnancy.
6. Is DILBRO UNICAP the same as Ultibro Breezhaler?
Yes. Both contain Indacaterol and Glycopyrronium as active ingredients.
📲 WhatsApp Contact: https://wa.me/8801742433764
7. Do I need a prescription to buy DILBRO UNICAP 10mg?
Yes. It is a prescription-only medicine.
Medical Disclaimer
Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Indacaterol+Glycopyrronium is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.
